What are the recommended yearly screenings for a 67-year-old male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Yearly Screenings for a 67-Year-Old Male

For a 67-year-old male, yearly screenings should include colorectal cancer screening, cardiovascular risk assessment, prostate cancer screening through shared decision-making, lipid panel, diabetes screening, and abdominal aortic aneurysm screening if he has a smoking history.

Cancer Screenings

Colorectal Cancer

  • Recommended screening: Regular screening should continue until age 75 1
  • Options include:
    • Annual fecal immunochemical test (FIT)
    • Annual high-sensitivity guaiac-based fecal occult blood test (HSgFOBT)
    • Multitarget stool DNA test every 3 years
    • Colonoscopy every 10 years
    • CT colonography every 5 years
    • Flexible sigmoidoscopy every 5 years 1
  • All positive results on non-colonoscopy screening tests should be followed up with timely colonoscopy

Prostate Cancer

  • Shared decision-making approach is strongly recommended for PSA screening in men aged 55-69 years 1
  • At age 67, the decision should be based on:
    • Individual risk factors (family history, African-American ethnicity)
    • Overall health status and life expectancy (benefit primarily for those with >10-year life expectancy)
    • Personal preferences after discussion of benefits and harms 1
  • If screening is chosen, a 2-year interval may be preferred over annual screening to reduce harms 1

Cardiovascular Screenings

Blood Pressure

  • Annual blood pressure measurement is reasonable 1
  • Target: <130/80 mmHg for most patients with diabetes or cardiovascular risk factors

Lipid Disorders

  • Lipid panel screening (total cholesterol, HDL, LDL, triglycerides)
  • Screening interval: Every 5 years is reasonable when previous results are normal 1
  • More frequent screening for those with abnormal values or multiple risk factors

Diabetes Screening

  • Fasting plasma glucose, HbA1c, or oral glucose tolerance test
  • Recommended every 3 years for men with BMI ≥25 kg/m² 1, 2
  • More frequent screening for those with prediabetes, hypertension, or obesity

Abdominal Aortic Aneurysm

  • One-time ultrasound screening is strongly recommended for men aged 65-75 years with a history of smoking 3
  • May be considered for men ≥75 years regardless of smoking history 3

Bone Health

Osteoporosis Screening

  • DEXA scanning is appropriate for men aged 70 and older 3
  • Earlier screening for those with risk factors for osteoporosis

Implementation Considerations

Risk Stratification

  • Cardiovascular risk assessment should incorporate multiple factors including age, blood pressure, lipid levels, diabetes status, and smoking history 1
  • Higher BMI (≥30 kg/m²) warrants more aggressive screening for diabetes and lipid disorders 2

Common Pitfalls to Avoid

  1. Under-screening in seemingly healthy individuals - Even asymptomatic men require regular screening based on age alone
  2. Over-screening - More frequent testing than recommended doesn't improve outcomes and increases costs
  3. Focusing on screening without addressing modifiable risk factors - All screening should be accompanied by counseling on smoking cessation, diet, and physical activity 1
  4. Neglecting shared decision-making for prostate cancer screening - The PSA test should never be ordered without discussing potential benefits and harms with the patient 1

Special Considerations

  • If the patient has diabetes, more intensive cardiovascular risk factor management is essential as diabetes significantly increases cardiovascular risk 4, 5, 6
  • For patients with limited life expectancy (<10 years), some screening tests (particularly prostate and colorectal cancer screening) may provide little benefit while still carrying risks of harm

By following these evidence-based screening recommendations, clinicians can help identify health risks early and potentially reduce morbidity and mortality in 67-year-old male patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Screening Guidelines for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.